Literature DB >> 31350467

Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms.

Cristina Renzi1,2, Aradhna Kaushal3, Jon Emery4, Willie Hamilton5, Richard D Neal6, Bernard Rachet7, Greg Rubin8, Hardeep Singh9, Fiona M Walter10, Niek J de Wit11, Georgios Lyratzopoulos3,10.   

Abstract

An earlier diagnosis is a key strategy for improving the outcomes of patients with cancer. However, achieving this goal can be challenging, particularly for the growing number of people with one or more chronic conditions (comorbidity/multimorbidity) at the time of diagnosis. Pre-existing chronic diseases might affect patient participation in cancer screening, help-seeking for new and/or changing symptoms and clinicians' decision-making on the use of diagnostic investigations. Evidence suggests, for example, that pre-existing pulmonary, cardiovascular, neurological and psychiatric conditions are all associated with a more advanced stage of cancer at diagnosis. By contrast, hypertension and certain gastrointestinal and musculoskeletal conditions might be associated with a more timely diagnosis. In this Review, we propose a comprehensive framework that encompasses the effects of disease-specific, patient-related and health-care-related factors on the diagnosis of cancer in individuals with pre-existing chronic illnesses. Several previously postulated aetiological mechanisms (including alternative explanations, competing demands and surveillance effects) are integrated with newly identified mechanisms, such as false reassurances, or patient concerns about appearing to be a hypochondriac. By considering specific effects of chronic diseases on diagnostic processes and outcomes, tailored early diagnosis initiatives can be developed to improve the outcomes of the large proportion of patients with cancer who have pre-existing chronic conditions.

Entities:  

Mesh:

Year:  2019        PMID: 31350467     DOI: 10.1038/s41571-019-0249-6

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  136 in total

Review 1.  Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.

Authors:  Farhat V N Din; Evropi Theodoratou; Susan M Farrington; Albert Tenesa; Rebecca A Barnetson; Roseanne Cetnarskyj; Lesley Stark; Mary E Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  Gut       Date:  2010-09-15       Impact factor: 23.059

Review 2.  Interaction between comorbidity and cancer.

Authors:  Martine Extermann
Journal:  Cancer Control       Date:  2007-01       Impact factor: 3.302

Review 3.  Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.

Authors:  Annemijn M Algra; Peter M Rothwell
Journal:  Lancet Oncol       Date:  2012-03-21       Impact factor: 41.316

Review 4.  Improving early diagnosis of symptomatic cancer.

Authors:  Willie Hamilton; Fiona M Walter; Greg Rubin; Richard D Neal
Journal:  Nat Rev Clin Oncol       Date:  2016-07-26       Impact factor: 66.675

Review 5.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

Review 6.  The impact of comorbidity on cancer and its treatment.

Authors:  Diana Sarfati; Bogda Koczwara; Christopher Jackson
Journal:  CA Cancer J Clin       Date:  2016-02-17       Impact factor: 508.702

7.  Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort.

Authors:  Veronica Wendy Setiawan; Daniel O Stram; Jacqueline Porcel; Suresh T Chari; Gertraud Maskarinec; Loïc Le Marchand; Lynne R Wilkens; Christopher A Haiman; Stephen J Pandol; Kristine R Monroe
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

8.  Association between patients' perception of the comorbidity burden and symptoms in outpatients with common solid tumors.

Authors:  Christine S Ritchie; Fengmin Zhao; Kanan Patel; Judith Manola; Elizabeth A Kvale; Claire F Snyder; Michael J Fisch
Journal:  Cancer       Date:  2017-06-13       Impact factor: 6.860

Review 9.  Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Authors:  Adi J Klil-Drori; Laurent Azoulay; Michael N Pollak
Journal:  Nat Rev Clin Oncol       Date:  2016-08-09       Impact factor: 66.675

10.  Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit.

Authors:  Ruth Swann; Sean McPhail; Jana Witt; Brian Shand; Gary A Abel; Sara Hiom; Jem Rashbass; Georgios Lyratzopoulos; Greg Rubin
Journal:  Br J Gen Pract       Date:  2017-12-18       Impact factor: 5.386

View more
  26 in total

1.  Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada.

Authors:  Colleen Webber; Marlo Whitehead; Andrea Eisen; Claire M B Holloway; Patti A Groome
Journal:  Breast Cancer Res Treat       Date:  2021-01-24       Impact factor: 4.872

2.  The future of diagnosis in general practice.

Authors:  William Hamilton
Journal:  Br J Gen Pract       Date:  2020-06-25       Impact factor: 5.386

3.  Factors influencing symptom appraisal and help-seeking of older adults with possible cancer: a mixed-methods systematic review.

Authors:  Daniel Jones; Erica Di Martino; Stephen H Bradley; Blessing Essang; Scott Hemphill; Judy M Wright; Cristina Renzi; Claire Surr; Andrew Clegg; Richard Neal
Journal:  Br J Gen Pract       Date:  2022-06-16       Impact factor: 6.302

4.  Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies: A National Registry Dataset Analysis.

Authors:  Nicolò Matteo Luca Battisti; Catherine A Welch; Michael Sweeting; Mark de Belder; John Deanfield; Clive Weston; Michael D Peake; David Adlam; Alistair Ring
Journal:  JACC CardioOncol       Date:  2022-06-21

5.  Do presenting symptoms, use of pre-diagnostic endoscopy and risk of emergency cancer diagnosis vary by comorbidity burden and type in patients with colorectal cancer?

Authors:  Sara Benitez Majano; Georgios Lyratzopoulos; Bernard Rachet; Niek J de Wit; Cristina Renzi
Journal:  Br J Cancer       Date:  2021-11-05       Impact factor: 9.075

6.  Multimorbidity in Patients With Acute Coronary Syndrome Is Associated With Greater Mortality, Higher Readmission Rates, and Increased Length of Stay: A Systematic Review.

Authors:  Katherine Breen; Lorna Finnegan; Karen Vuckovic; Anne Fink; Wayne Rosamond; Holli A DeVon
Journal:  J Cardiovasc Nurs       Date:  2020 Nov/Dec       Impact factor: 2.083

Review 7.  How Comorbidities Shape Cancer Biology and Survival.

Authors:  Gatikrushna Panigrahi; Stefan Ambs
Journal:  Trends Cancer       Date:  2021-01-11

8.  Morbidity and measures of the diagnostic process in primary care for patients subsequently diagnosed with cancer.

Authors:  Minjoung M Koo; Ruth Swann; Sean McPhail; Gary A Abel; Cristina Renzi; Greg P Rubin; Georgios Lyratzopoulos
Journal:  Fam Pract       Date:  2022-07-19       Impact factor: 2.290

9.  Routes to cancer diagnosis for patients with pre-existing psychiatric disorders: a nationwide register-based cohort study.

Authors:  Line Flytkjær Virgilsen; Peter Vedsted; Alina Zalounina Falborg; Anette Fischer Pedersen; Anders Prior; Henry Jensen
Journal:  BMC Cancer       Date:  2022-04-29       Impact factor: 4.638

10.  MK2206 attenuates atherosclerosis by inhibiting lipid accumulation, cell migration, proliferation, and inflammation.

Authors:  Ya-Qin Tang; Zhi-Wei Li; Yu-Fan Feng; Hong-Qin Yang; Cui-Liu Hou; Chi Geng; Pei-Ran Yang; Hong-Mei Zhao; Jing Wang
Journal:  Acta Pharmacol Sin       Date:  2021-07-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.